Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: A multicenter retrospective study (KROG 13-10)

Gynecologic Oncology

Volumn 132, Issue 3, 2014, Pages 618-623

  Noh, Jae Myoung ^a   Park, Won ^a   Kim, Young Seok ^b   Kim, Joo Young ^c   Kim, Hak Jae ^d   Kim, Juree ^e   Kim, Jin Hee ^f   Yoon, Mee Sun ^g   Choi, Jin Hwa ^h   Yoon, Won Sup ⁱ   Kim, Ji Yoon ^j   Huh, Seung Jae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Kwandong University College of Medicine   (South Korea)

^f Dongsan Medical Center   (South Korea)

^g Chonnam National University Medical School   (South Korea)

^h Chung Ang University   (South Korea)

ⁱ Korea University   (South Korea)

^j The Catholic University of Korea   (South Korea)

more..

Author keywords

Adenocarcinoma; Adenosquamous carcinoma; Cervical cancer; Postoperative radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; TAXANE DERIVATIVE;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPARATIVE STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; RADICAL HYSTERECTOMY; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TUMOR INVASION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; CERVICAL CANCER; POSTOPERATIVE RADIOTHERAPY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84896388076     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.01.043     Document Type: Article

References (28)

1. K.B. Lee, J.M. Lee, C.Y. Park, K.B. Lee, H.Y. Cho, and S.Y. Ha What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study Int J Gynecol Cancer 16 2006 1569 1573
2. T. Kasamatsu, T. Onda, M. Sawada, T. Kato, S. Ikeda, and Y. Sasajima et al. Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix Br J Cancer 100 2009 1400 1405
3. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, and J.H. Nam Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix Br J Cancer 102 2010 1692 1698
4. Y.Y. Lee, C.H. Choi, T.J. Kim, J.W. Lee, B.G. Kim, and J.H. Lee et al. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA Gynecol Oncol 120 2011 439 443
5. S. Mabuchi, M. Okazawa, K. Matsuo, M. Kawano, O. Suzuki, and T. Miyatake et al. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma Gynecol Oncol 127 2012 114 120
6. H.M. Shingleton, M.C. Bell, A. Fremgen, J.S. Chmiel, A.H. Russell, and W.B. Jones et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 76 1995 1948 1955
7. J.H. Farley, K.W. Hickey, J.W. Carlson, G.S. Rose, E.R. Kost, and T.A. Harrison Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma Cancer 97 2003 2196 2202
8. J.S. Lea, R.L. Coleman, E.O. Garner, L.R. Duska, D.S. Miller, and J.O. Schorge Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma Gynecol Oncol 91 2003 558 562
9. R. dos Reis, M. Frumovitz, M.R. Milam, E. Capp, C.C. Sun, and R.L. Coleman et al. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis Gynecol Oncol 107 2007 458 463
10. Y.T. Huang, C.C. Wang, C.S. Tsai, C.H. Lai, T.C. Chang, and H.H. Chou et al. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy Int J Radiat Oncol Biol Phys 84 2012 420 427
11. S. Mabuchi, M. Okazawa, Y. Kinose, K. Matsuo, M. Fujiwara, and O. Suzuki et al. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy Int J Gynecol Cancer 22 2012 1389 1397
12. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology Cervical Cancer 3 2013 [cited 2014 January 17, Available from: http://www.nccn.org/professionals/physician-gls/pdf/cervical.pdf ]
13. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R.J. Stock, B.J. Monk, and J.S. Berek et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
14. M. Rotman, A. Sedlis, M.R. Piedmonte, B. Bundy, S.S. Lentz, and L.I. Muderspach et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynecologic Oncology Group study Int J Radiat Oncol Biol Phys 65 2006 169 176
15. J.H. Hong, C.S. Tsai, C.C. Wang, C.H. Lai, W.C. Chen, and S.P. Lee et al. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix Chang Gung Med J 23 2000 396 404
16. Y.T. Huang, C.C. Wang, C.S. Tsai, C.H. Lai, T.C. Chang, and H.H. Chou et al. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy Int J Radiat Oncol Biol Phys 80 2011 429 436
17. K. Katanyoo, S. Sanguanrungsirikul, and S. Manusirivithaya Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer Gynecol Oncol 125 2012 292 296
18. E. Kastritis, A. Bamias, E. Efstathiou, D. Gika, G. Bozas, and P. Zorzou et al. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy Gynecol Oncol 99 2005 376 382
19. S. Nagao, K. Fujiwara, T. Oda, H. Ishikawa, H. Koike, and H. Tanaka et al. Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study Gynecol Oncol 96 2005 805 809
20. Y.B. Kim, G.E. Kim, N.H. Cho, H.R. Pyo, S.J. Shim, and S.K. Chang et al. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy Cancer 95 2002 531 539
21. Y.B. Kim, G.E. Kim, H.R. Pyo, N.H. Cho, K.C. Keum, and C.G. Lee et al. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 60 2004 822 829
22. H. Ishikawa, T. Ohno, S. Kato, M. Wakatsuki, M. Iwakawa, and T. Ohta et al. Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis Int J Radiat Oncol Biol Phys 66 2006 1347 1355
23. J.M. Noh, W. Park, S.J. Huh, E.Y. Cho, Y.L. Choi, and J.H. Lee et al. Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma J Gynecol Oncol 20 2009 215 220
24. J.M. Noh, W. Park, S.J. Huh, E.Y. Cho, Y.L. Choi, and D.S. Bae et al. Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients Radiat Oncol J 30 2012 218 225
25. F. Baltazar, A.L. Filho, C. Pinheiro, M.A. Moreira, G.S. Queiroz, and G.J. Oton et al. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas Int J Gynecol Pathol 26 2007 235 241
26. D.K. Gaffney, K. Winter, A.P. Dicker, B. Miller, P.J. Eifel, and J. Ryu et al. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128 Int J Radiat Oncol Biol Phys 69 2007 111 117
27. M.L. Tornesello, L. Buonaguro, and F.M. Buonaguro Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review Gynecol Oncol 128 2013 442 448
28. E. Nakamura, M. Iwakawa, R. Furuta, T. Ohno, T. Satoh, and M. Nakawatari et al. Villin1, a novel diagnostic marker for cervical adenocarcinoma Cancer Biol Ther 8 2009 1146 1153